Oncology Nursing Drug Handbook 4.4.1

The 2018 Oncology Nursing Drug Handbook serves as an essential resource tailored for oncology nurses who provide care to patients with cancer. The accompanying free app allows access to approximately 10% of the content, with further topics accessible via in-app purchases.

This handbook adeptly integrates drug therapy within the nursing process, featuring nursing diagnoses, the etiology of toxicities, and critical points for assessment, intervention, and evaluation. As an annually updated reference, it presents vital information aimed at effective symptom management, patient education, and the administration of chemotherapy.

The complete overhaul in the 2017 edition includes dedicated chapters on molecular and immunologic/biologic targeted therapies. These chapters encompass essential reviews that assist nurses in comprehending the cellular communication pathways disrupted by cancer. Additionally, this edition streamlines content related to immune checkpoint inhibitors and incorporates recent developments in immunotherapy, offering insights into new drugs and updated indications and side effects for recently FDA-approved therapies.

Among the newly included medications are: alectinib (Alecensa), atezolizumab (Tecentriq), cabozantinib tablets (Cabometyx), cabozantinib capsules (Cometriq), cobimetinib tablets (Cotellic), daratumumab (Darzalex), elotuzumab (Empliciti), and many others, reflecting a comprehensive approach to oncology pharmacology.

Table of Contents:

1. Cancer Treatment
   1. Introduction to Chemotherapy Drugs
   2. Biologic Response Modifier Therapy
   3. Cytoprotective Agents
   4. Molecularly Targeted Therapies
   5. Chemobiotherapy for Noncancer Diseases
2. Symptom Management
   1. Pain
   2. Nausea and Vomiting
   3. Anorexia and Cachexia
   4. Anxiety and Depression
3. Complications
   1. Managing Tumor-Related Skeletal Events and Hypercalcemia
   2. Infection
   3. Constipation
   4. Diarrhea
4. Appendices
   1. Occupational Exposure to Hazardous Drugs
   2. Common Terminology Criteria for Adverse Events (CTCAE)

Author:
Gail M. Wilkes, MS, APRN-BC, AOCN - Oncology Nursing Consultant, Kilauea, Hawaii
ISBN-13: 9781284117189
ISBN-10: 1284117189